Service interruption on Monday 11 July from 12:30 to 13:00: all the sites of the CCSD (HAL, Epiciences, SciencesConf, AureHAL) will be inaccessible (network hardware connection).
Skip to Main content Skip to Navigation
Journal articles

Bortezomib, C1-Inhibitor and Plasma Exchange Do Not Prolong the Survival of Multi-Transgenic GalT-KO Pig Kidney Xenografts in Baboons

S. Le Bas-Bernardet 1, 2, 3, 4 X. Tillou 1, 2 J. Branchereau 1, 2 N. Dilek 1, 2, 5 N. Poirier 1, 2, 5 M. Châtelais 1, 2, 3, 4 B. Charreau 1, 2, 3, 4 D. Minault 1, 2 J. Hervouet 1, 2 K. Renaudin 6 C. Crossan 3, 4, 7 L. Scobie 3, 4, 7 y. Takeuchi 4, 3, 8 M. Diswall 9 M. E Breimer 9 N. Klar 4, 3, 10 M. R Daha 3, 4, 10 P. Simioni 11 S. C Robson 12 M. B Nottle 13 E J Salvaris 14 P J Cowan 14 A J F d'Apice 14 D. H Sachs 15 K. yamada 15 I. Lagutina 16 R. Duchi 16 A. Perota 16 G. Lazzari 16 C. Galli 16, 17 E. Cozzi 3, 4 J.-P Soulillou 1, 2 B. Vanhove 1, 2, 5 Gilles Blancho 1, 2, * 
Abstract : Galactosyl-transferase knockout (GalT-KO) pigs represent a potential solution to xenograft rejection, particularly in the context of additional genetic modifications. We have performed life supporting kidney xenotransplantation into baboons utilizing GalT-KO pigs transgenic for human CD55/CD59/CD39/HT. Baboons received tacrolimus, mycophenolate mofetil, corticosteroids and recombinant human C1 Inhibitor combined with cyclophosphamide or bortezomib with or without 2–3 plasma exchanges. One baboon received a control GalT-KO xenograft with the latter immunosuppression. All immunosuppressed baboons rejected the xenografts between days 9 to 15 with signs of acute humoral rejection, in contrast to untreated controls (n=2) which lost their grafts on day 3 and 4. Immunofluorescence analyses showed deposition of IgM, C3, C5b-9 in rejected grafts, without C4d staining, indicating classical complement pathway blockade but alternate pathway activation. Moreover, rejected organs exhibited predominantly monocyte/macrophage infiltration with minimal lymphocyte representation. None of the recipients showed any signs of PERV transmission but some showed evidence of PCMV replication within the xenografts. Our work indicates that the addition of bortezomib and plasma exchange to the immunosuppressive regimen did not significantly prolong the survival of multi-transgenic GalT-KO renal xenografts. Non-Gal antibodies, the alternative complement pathway, innate mechanisms with monocyte activation and PCMV replication may have contributed to rejection.
Document type :
Journal articles
Complete list of metadata

Cited literature [39 references]  Display  Hide  Download
Contributor : Sylvie Le Bihan Connect in order to contact the contributor
Submitted on : Wednesday, June 5, 2019 - 3:12:10 PM
Last modification on : Wednesday, April 27, 2022 - 4:07:36 AM


 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : jamais

Please log in to resquest access to the document




S. Le Bas-Bernardet, X. Tillou, J. Branchereau, N. Dilek, N. Poirier, et al.. Bortezomib, C1-Inhibitor and Plasma Exchange Do Not Prolong the Survival of Multi-Transgenic GalT-KO Pig Kidney Xenografts in Baboons. American Journal of Transplantation, Wiley, 2015, 15 (2), pp.358-370. ⟨10.1111/ajt.12988⟩. ⟨inserm-02148475⟩



Record views